BRIEF-Medexus Pharmaceuticals Q2 Adjusted EBITDA USD 5.079 Million
BRIEF-Medexus Pharmaceuticals Q2 Adjusted EBITDA USD 5.079 Million Nov 11 (Reuters) - Medexus Pharma
Related stories
Lucara Diamond Raises 2026 Revenue Guidance to USD 140 Million-160 Million
Lucara Diamond Raises 2026 Revenue Guidance to USD 140 Million-160 Million Lucara Diamond raised
L impact | EARNINGS | Nov 14, 2026, 01:10 AM UTC
Fed’s Jefferson Says AI Buildout Raises Aggregate Demand Concerns
Jefferson said aggregate demand is a source of inflationary pressure and that the AI buildout makes him mindful of it.
M impact | CENTRAL_BANK | Nov 14, 2026, 12:57 AM UTC
Fed’s Jefferson Says FOMC Will Hear From Task Forces Soon
Jefferson said the FOMC will hear from Fed task forces in a matter of months, if not sooner.
L impact | CENTRAL_BANK | Nov 14, 2026, 12:45 AM UTC
Fed’s Jefferson Says Debt and Deficits Have Not Entered Policy Debate
Fed Vice Chair Philip Jefferson said debt or deficit issues have never, in his experience, entered the Fed’s policy debate.
L impact | CENTRAL_BANK | Nov 14, 2026, 12:36 AM UTC
Fed’s Jefferson Says Inflation Trajectory Matters Most for Policy Rates
M impact | CENTRAL_BANK | Nov 14, 2026, 12:00 AM UTC
US Dollar Edges Higher Against Canadian Dollar
The US dollar climbed slightly against Canada's currency.
M impact | FX | Nov 13, 2026, 06:38 PM UTC